StonvexLoading…
StonvexStonvexStonvexCore line items from KTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.15B | $2.61B | $2.61B | $2.63B |
Operating Income | $336.81M | $342.29M | $319.27M | $356.67M |
Net Income | $227.45M | $245.80M | $230.99M | $245.49M |
EPS (Diluted) | $4.05 | $4.36 | $4.06 | $4.31 |
Total Assets | $2.58B | $1.65B | $1.65B | $1.58B |
Total Liabilities | $2.02B | $1.25B | $1.27B | $1.33B |
Cash & Equivalents | $108.44M | $334.07M | $215.05M | $59.18M |
Free Cash Flow OCF − CapEx | $434.76M | $349.44M | $329.18M | $65.21M |
Shares Outstanding | 55.24M | 55.31M | 55.72M | 55.52M |